Growth Metrics

Insulet (PODD) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 81.87%
Dec 31, 2025 -392.90%
Sep 30, 2025 -33.05%
Jun 30, 2025 -49.36%
Mar 31, 2025 77.06%
Dec 31, 2024 -132.08%
Sep 30, 2024 -17.67%
Jun 30, 2024 -3.75%
Mar 31, 2024 24.05%
Dec 31, 2023 -39.82%
Sep 30, 2023 2.16%
Jun 30, 2023 45.13%
Mar 31, 2023 52.38%
Dec 31, 2022 -160.77%
Sep 30, 2022 -54.79%
Jun 30, 2022 53.30%
Mar 31, 2022 -28.85%
Dec 31, 2021 -198.36%
Sep 30, 2021 -7.02%
Jun 30, 2021 49.78%
Mar 31, 2021 67.24%
Dec 31, 2020 -2,666.67%
Sep 30, 2020 -95.98%
Jun 30, 2020 401.49%
Mar 31, 2020 124.81%
Dec 31, 2019 -542.62%
Sep 30, 2019 130.96%
Jun 30, 2019 -618.42%
Mar 31, 2019 118.64%
Dec 31, 2018 -53.22%
Sep 30, 2018 56.45%
Jun 30, 2018 -9.16%
Mar 31, 2018 62.50%
Dec 31, 2017 -5,469.11%
Sep 30, 2017 112.65%
Jun 30, 2017 48.02%
Mar 31, 2017 56.49%
Dec 31, 2016 -115.78%
Sep 30, 2016 -20.94%
Jun 30, 2016 -2,661.35%
Mar 31, 2016 141.76%
Dec 31, 2015 51.91%
Sep 30, 2015 -2,739.22%
Jun 30, 2015 94.13%
Mar 31, 2015 -65.06%
Dec 31, 2014 15.28%
Sep 30, 2014 13.38%
Jun 30, 2014 -66.34%
Mar 31, 2014 22.69%
Dec 31, 2013 -53.13%
Sep 30, 2013 -12.05%
Jun 30, 2013 -52.10%
Mar 31, 2013 47.98%
Dec 31, 2012 56.16%
Sep 30, 2012 -83.80%
Jun 30, 2012 -50.09%
Mar 31, 2012 25.35%
Dec 31, 2011 30.57%
Sep 30, 2011 91.91%
Jun 30, 2011 -1,298.62%
Mar 31, 2011 0.69%
Dec 31, 2010 -77.22%